“Comfort begins with respect,” InnVest hotel customers hear from United Steelworkers union members

MONTREAL, Jan. 27, 2025 (GLOBE NEWSWIRE) — The United Steelworkers union (USW) has launched a Canada-wide campaign to raise awareness among customers of the InnVest Group hotel chain regarding the treatment of women embroiled in a 10-month strike over low wages. The campaign is supporting workers, mostly women, at InnVest's Comfort Inn hotel in Baie-Comeau, […]

Oxford Lane Capital Corp. Announces Net Asset Value and Selected Financial Results for the Third Fiscal Quarter and Declaration of Distributions on Common Stock for the Months Ending April, May, and June 2025

(NASDAQ:OXLCO),(NasdaqGM:OXLC),(NASDAQ:OXLCP),(NASDAQ:OXLCL),(NASDAQ:OXLCZ),(NASDAQ:OXLCN),(NASDAQ:OXLCI), GREENWICH, Conn., Jan. 27, 2025 (GLOBE NEWSWIRE) — Oxford Lane Capital Corp. (Nasdaq: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) (NasdaqGS: OXLCN) (NasdaqGS: OXLCI) (“Oxford Lane,” the “Company,” “we,” “us” or “our”) announced today the following financial results and related information: On January 24, 2025, our Board of Directors declared the following

Supernus Announces Label Update for Non-Stimulant ADHD Treatment, Qelbree(R), Including New Pharmacodynamic Data and Information for Breastfeeding Women

(NasdaqGM:SUPN), Updated label includes new data in Section 12.2, detailing serotonin 5-HT2C partial agonist activity and norepinephrine transporter inhibition, highlighting Qelbree's multimodal pharmacodynamics Qelbree is the first ADHD treatment to meet its post marketing requirement and receive labeling approval following the 2019 FDA guidance on Clinical Lactation Studies1 ROCKVILLE, Md., Jan. 27, 2025 (GLOBE NEWSWIRE)

Benitec Biopharma to Participate in Upcoming Conferences in January and February

(NASDAQ:BNTC), HAYWARD, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) — Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace” DNA-directed RNA interference (“ddRNAi”) platform, today announced that its management team will participate in the following upcoming conferences. Muscular Dystrophy

DECEMBER 2024: ELFA CapEx Finance Index Shows New Business Volumes Surged at Year-End

FORECAST: Growth in new business volumes suggests durable goods orders will expand by 0.35% in December Total new business volume (NBV) rose by $11.4 billion, a jump of 8.1% from November to December among surveyed ELFA member companies NBV expanded by 4.2% from 2023 to 2024 Charge-offs (losses) dropped to 0.52%, after rising in the

Integral Metals Announces the Acquisition of the Woods Creek Project in Montana

(CNSX:INTG.CN),(Boerse Frankfurt – Freiverkehr:ZK9), CALGARY, Alberta, Jan. 27, 2025 (GLOBE NEWSWIRE) — Integral Metals Corp. (CSE: INTG | FSE: ZK9) (the “Company” or “Integral”) is pleased to announce the acquisition of its Woods Creek Project, located within the Idaho Rare Earth Elements-Thorium (REE-Th) Belt in southwestern Montana. This strategic addition to the Company's portfolio includes

The Colt Group Acquires RJ Stacey

HOUSTON, Jan. 27, 2025 (GLOBE NEWSWIRE) — The Colt Group (“Colt”), a provider of on-line industrial leak repair solutions, announced today that it has acquired RJ Stacey (“RJ Stacey” or “the Company”). Terms of the transaction were not disclosed. Founded in 1990 and headquartered in Lake Orion, MI, RJ Stacey provides online leak repair, hot

Acuitive Technologies, Inc. Appoints Dr. Wayne Berberian as Chief Medical Officer

ALLENDALE, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) — Acuitive Technologies (Acuitive), a leading orthopedic medical device company focused on complex soft tissue repair and regeneration, announces the appointment of Wayne Berberian, M.D. as Chief Medical Officer. He will provide the clinical direction for the development of regenerative orthopedic products from the company's portfolio of innovative

Life Biosciences Appoints Dr. Michael Ringel as Chief Operating Officer

BOSTON, Jan. 27, 2025 (GLOBE NEWSWIRE) — Life Biosciences (“Life Bio”), a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging, today announced the appointment of Michael Ringel, Ph.D., J.D., as Chief Operating Officer. “Michael is a recognized leader with decades of experience driving innovation and strategy in the biotech

Global Uranium Announces Preliminary GIS Compilation Work for Wyoming Properties

(CNSX:GURN.CN),(OTC US:GURFF),(Other OTC:GURFF),(Boerse Frankfurt – Freiverkehr:Q3J.F),(Boerse Frankfurt – Freiverkehr:Q3J), CALGARY, Alberta, Jan. 27, 2025 (GLOBE NEWSWIRE) — Global Uranium Corp. (CSE: GURN | OTC: GURFF | FRA: Q3J) (the “Company“) is pleased to announce the completion of preliminary GIS database compilation work for its uranium properties in Wyoming. Conducted by Big Rock Exploration (“BRE”), this

Scroll to Top